Enolex Injection 40mg 60mg is a high-purity, low molecular weight heparin (LMWH) formulation containing Enoxaparin Sodium, manufactured by Lexine Technochem India, a WHO-GMP and ISO-certified pharmaceutical company. Enolex is used as an anticoagulant for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and as part of the management of acute coronary syndromes (ACS) such as unstable angina and non-Q wave myocardial infarction. Each prefilled syringe delivers sterile, pyrogen-free Enoxaparin, formulated for subcutaneous administration, ensuring rapid onset and sustained anticoagulant action with a predictable pharmacokinetic profile. The formulation is DCGI-approved, meets IP/BP/USP standards, and is produced under strict aseptic conditions in cleanroom environments. Enolex Injection is widely recommended in post-operative thromboprophylaxis, especially after orthopedic and abdominal surgeries, and offers a safe and effective alternative to unfractionated heparin. It is supplied in both 40mg/0.4ml and 60mg/0.6ml strengths for flexible dosing based on body weight and indication. Lexine Technochem India offers Enolex for bulk institutional supply, hospital tenders, export, and third-party manufacturing, supported by full regulatory documentation including COA, MSDS, and Dossier. As a trusted Indian manufacturer and global exporter of injectable anticoagulants, we ensure consistent quality, prompt delivery, and customizable private label options. Contact us today for export pricing, OEM partnerships, or large-volume procurement.